Serotonin and Migraine
PATRICK P. A. HUMPHREY,
WASYL FENIUK,
MARION J. PERREN,
ISABEL J. M. BERESFORD,
MALCOLM SKINGLE,
ERIC T. WHALLEY,
PATRICK P. A. HUMPHREY
Pharmacology Division Glaxo Group Research Limited Ware, Hertfordshire, SG12 ODP, England
Search for more papers by this authorWASYL FENIUK
Pharmacology Division Glaxo Group Research Limited Ware, Hertfordshire, SG12 ODP, England
Search for more papers by this authorMARION J. PERREN
Pharmacology Division Glaxo Group Research Limited Ware, Hertfordshire, SG12 ODP, England
Search for more papers by this authorISABEL J. M. BERESFORD
Pharmacology Division Glaxo Group Research Limited Ware, Hertfordshire, SG12 ODP, England
Search for more papers by this authorMALCOLM SKINGLE
Pharmacology Division Glaxo Group Research Limited Ware, Hertfordshire, SG12 ODP, England
Search for more papers by this authorERIC T. WHALLEY
Department of Physiological Sciences University of Manchester Manchester, M13 9PT, England
Search for more papers by this authorPATRICK P. A. HUMPHREY,
WASYL FENIUK,
MARION J. PERREN,
ISABEL J. M. BERESFORD,
MALCOLM SKINGLE,
ERIC T. WHALLEY,
PATRICK P. A. HUMPHREY
Pharmacology Division Glaxo Group Research Limited Ware, Hertfordshire, SG12 ODP, England
Search for more papers by this authorWASYL FENIUK
Pharmacology Division Glaxo Group Research Limited Ware, Hertfordshire, SG12 ODP, England
Search for more papers by this authorMARION J. PERREN
Pharmacology Division Glaxo Group Research Limited Ware, Hertfordshire, SG12 ODP, England
Search for more papers by this authorISABEL J. M. BERESFORD
Pharmacology Division Glaxo Group Research Limited Ware, Hertfordshire, SG12 ODP, England
Search for more papers by this authorMALCOLM SKINGLE
Pharmacology Division Glaxo Group Research Limited Ware, Hertfordshire, SG12 ODP, England
Search for more papers by this authorERIC T. WHALLEY
Department of Physiological Sciences University of Manchester Manchester, M13 9PT, England
Search for more papers by this author
References
- 1
N. H. Raskin, Ed.
1988. Headache. 2d edit.
New York
: Churchill Livingston.
- 2
Linet, M. S. &
W. F. Stewart
1987. The epidemiology of migraine headache. In
Migraine—Clinical, therapeutic, conceptual and research aspects. J. N. Blau, Ed.
London
: Chapman and Hall, pp.
451–477.
- 3
Blau, J. N.
1987. Migraine—Clinical, therapeutic, conceptual and research aspects.
London
: Chapman and Hall.
- 4
Lashley, K. S.
1941. Arch.
Neurol Psychiatry (Chicago)
46: 331–339.
- 5
Lance, J. W.
1973. The mechanism and management of headache. 2nd edit.
London
: Butterworths.
- 6
Lance, J. W. &
M. Anthony
1966. Arch. Neurol. 15: 356–361.
- 7
Olesen, J.,
A. Bes,
R. Kunkel,
J. W. Lance,
G. Nappi,
V. Pfaffenrath,
F. C. Rose,
B. S. Schoenberg,
D. Soyka,
P. Tfelt-Hansen,
K. M. A. Welch &
M. Wilkinson
1988. Cephalalgia
8 (Suppl. 7): 1–96.
- 8
Graham, J. R. &
H. G. Wolff
1938. Arch.
Neurol. Psychiatry (Chicago)
39: 737–763.
- 9
Wolff, H. G.
1963. Headache and other head pain.
London
: Oxford University Press.
- 10
Raskin, N. H.
1981. Ann. Rev. Pharmac. Toxicol. 21: 463–478.
- 11
Lance, J. W.,
G. A. Lambert,
P. J. Goadsby &
A. S. Zagami
1989. Cephalalgia
8 (Suppl. 9): 7–13.
- 12
Sicuteri, F.,
A. Testi &
B. Anselmi
1961. Int.
Arch. Allergy
19: 55–58.
- 13
Curran, D. A.,
H. Hinterberger &
J. W. Lance
1965. Brain
88: 997–1007.
- 14
Anthony, M.,
H. Hinterberger &
J. W. Lance
1967. Arch. Neurol. 16: 544–552.
- 15
Kimball, R. W.,
A. P. Friedman &
E. Valeejo
1960. Neurology
10: 107–111.
- 16
Anthony, M.,
H. Hinterberger &
J. W. Lance
1969. Res.
Clin. Study Headache
2: 29–59.
- 17
Fozard, J. R.
1982. Prog. Pharmacol. 4/4: 134–146.
- 18
Ostfeld, A. M. &
H. G. Wolff
1955. Arch.
Neurol. Psychiatry (Chicago)
74: 131.
- 19
Peatfield, R. C.,
J. R. Fozard &
F. C. Rose
1986. Handbook of Clin.
Neurology
4: 173–216.
- 20
Leysen, J. E.,
C. J. E. Niemegeers
J. M. Van Nueten &
P. M. Laduron
1982. Mol. Pharmacol. 21: 301–314.
- 21
Fozard, J. R.
1975. J. Pharm. Pharamacol. 27: 297–321.
- 22
Engel, G.,
M. Göthert,
D. Hoyer,
E. Schlicker &
K. Hillenbrand
1986. Naunyn Schmiedebergs Arch.
Pharmacol. 332: 107.
- 23
Herrick-Davis, K. &
M. Titeler
1988. J. Neurochem. 50: 1624–1631.
- 24
Affolter, H.,
W. P. Burkard &
A. Pletscher
1985. Eur. J. Pharmacol. 108: 157–162.
- 25
Auguet, M.,
S. Delaflotte,
F. Clostre &
F. V. Defeudis
1986. Gen. Pharmacol. 17(2): 133–135.
- 26
Peroutka, S. J.
1988. Ann. Neurol. 23: 500–504.
- 27
Berde, B. &
H. O. Schild
1978. Ergot alkaloids and related compounds. Handbook of Experimental Pharmacology
Vol. 49.
New York
: Springer-Verlag.
- 28
Loisy, C.,
S. Beorchia,
V. Centonze,
J. R. Fozard,
P. J. Schechter &
G. P. Tell
1986. Cephalalgia
5: 79–82.
- 29
Van Heuven-Nolsen, D.
1988. Trends in Pharmacol.
Sci. 9: 423–425.
- 30
Lataste, X.
1988. Unpublished observations reported at International Symposium: Cardiovascular Pharmacology of 5-Hydroxytryptamine, October 1988,
Amsterdam
,
The Netherlands
.
- 31
Doenicke, A.,
J. Brand &
V. L. Perrin
1988. Lancet
I: 1309–1311.
- 32
Humphrey, P. P. A.,
W. Feniuk,
M. J. Perren,
H. E. Connor &
A. W. Oxford
1989. Cephalalgia
9 (Suppl. 9): 23–33.
- 33
Humphrey, P. P. A.,
W. Feniuk,
M. J. Perren,
H. E. Connor,
A. W. Oxford,
I. H. Coates &
D. Butina
1988. Br. J. Pharmacol. 94: 1123–1132.
- 34
Perren, M. J.,
W. Feniuk &
P. P. A. Humphrey
1989. Cephalalgia
9 (Suppl. 9): 41–46.
- 35
Humphrey, P. P. A.,
W. Feniuk,
M. J. Perren,
A. W. Oxford &
R. T. Brittain
1989. Drugs of the Future
14(1): 35–39.
- 36
Feniuk, W.,
P. P. A. Humphrey &
M. J. Perren
1989. Br. J. Pharmacol. 96: 83–90.
- 37
Feniuk, W.,
P. P. A. Humphrey &
M. J. Perren
1989. Cephalalgia
9 (Suppl. 9): 35–39.
- 38
Peroutka, S. J. &
B. G. McCarthy
1989. Eur. J. Pharmacol. 163: 133–136.
- 39
Feniuk, W.,
P. P. A. Humphrey &
A. D. Watts
1981. J. Auton. Pharmacol. 1: 127–132.
- 40
Middlemiss, D. N.,
M. E. Bremer &
S. M. Smith
1988. Eur. J. Pharmacol. 157: 101–107.
- 41
Hoyer, D. &
P. Schoeffter
1988. Eur. J. Pharmacol. 147: 145–147.
- 42
Sumner, M. J. &
P. P. A. Humphrey
1989. Br. J. Pharmacol. 98: 29–31.
- 43
Fujiwara, M.,
H. Hayashi,
I. Muramatsu &
N. Ueda
1984. J. Physiol. 350: 580–597.
- 44
Ueda, N.,
I. Muramatsu,
H. Hayashi &
M. Fujiwara
1982. Life Sci. 31: 369–375.
- 45
Blau, J. N.
1978. Lancet
I; 1136–1139.
- 46
Reinhard, J. F.,
J. E. Leibman,
A. J. Schlosberg &
M. A. Moskowitz
1979. Science
206: 85–87.
- 47
Fozard, J. R.
1982. Basic mechanisms of antimigraine drugs. In
International Headache Congress. M. Critchley, Eds. et al., Eds.
New York
: Raven Press, pp.
295–308.
- 48
Bradley, P. B.,
G. Engel,
W. Feniuk,
J. R. Fozard,
P. P. A. Humphrey,
D. N. Middlemiss,
E. J. Mylecharane,
B. P. Richardson &
P. R. Saxena
1986. Neuro-pharmacology
25(6): 563–576.
- 49
Paintal, A. S.
1973. Physiol. Rev. 53: 159–227.
- 50
Butler, A.,
J. M. Hill,
S. J. Ireland,
C. C. Jordan &
M. B. Tyers
1988. Br. J. Pharmacol. 94: 397–412.
- 51
Connor, H. E.,
W. Feniuk &
P. P. A. Humphrey
1989. Br. J. Pharmacol. 96: 379–387.
- 52
Parsons, A. A.,
E. T. Whalley,
W. Feniuk,
H. E. Connor &
P. P. A. Humphrey
1989. Br. J. Pharmacol. 96: 434–449.
- 53
Moskowitz, M. A.
1984. Ann. Neurol. 16: 157–168.
- 54
Friberg, L.
1989. Cephalalgia
9 (Suppl. 10): 359–360.
- 55
Saito, K.,
S. Markowitz &
M. A. Moskowitz
1988. Ann. Neurol. 24: 732–737.
- 56
Buzzi, M. G. &
M. A. Moskowitz
1989. Cephalalgia
9 (Suppl. 10): 27–28.
- 57
Perrin, V. I.,
M. Färkkilä,
J. Goasguen,
A. Doenicke,
J. Brand &
P. Tfelt-Hansen
1989. Cephalalgia
9 (Suppl. 9): 63–72.
Citing Literature
